Proteostasis Therapeutics, Inc. Made Headway
Tue, Nov 26, 2019 at 05:30 PM
Proteostasis Therapeutics, Inc. (PTI:NASDAQ) rocketted at $2.4, representing a gain of 27%. On Mon 25 Nov 19, PTI:NASDAQ touched a New 2-Week High of $1.89. The stock appeared on our News Catalysts scanner on Thu 14 Nov 19 at 03:38 PM in the 'RECOMMENDATION' category. From Tue 05 Nov 19, the stock recorded 78.57% Up Days and 73.33% Green Days
About Proteostasis Therapeutics, Inc. (PTI:NASDAQ)
Proteostasis Therapeutics Inc operates in the healthcare sector of United States. Its business involves the discovery and development of therapeutics to correct the imbalance of the protein biosynthesis process.
Top 10 Gainers:
- ChemoCentryx, Inc. (CCXI:NASDAQ), 281.27%
- Baudax Bio, Inc. (BXRX:NASDAQ), 50.44%
- Cleveland BioLabs, Inc. (CBLI:NASDAQ), 48.78%
- ToughBuilt Industries, Inc. (TBLT:NASDAQ), 43.75%
- SG Blocks, Inc. (SGBX:NASDAQ), 29.62%
- China Ceramics Co., Ltd. (CCCL:NASDAQ), 29.17%
- Hepion Pharmaceuticals, Inc. (HEPA:NASDAQ), 28.69%
- Proteostasis Therapeutics, Inc. (PTI:NASDAQ), 26.98%
- Akerna Corp. (KERN:NASDAQ), 26.59%
- CymaBay Therapeutics, Inc. (CBAY:NASDAQ), 24.81%